Toripalimab, CAS [[1924598-82-2]]

Produktübersicht

• Artikelname: Toripalimab, CAS [[1924598-82-2]]
• Artikelnummer: TGM-T77117
• Hersteller Artikelnummer: T77117
• Alternativnummer: TGM-T77117-1MG,TGM-T77117-5MG,TGM-T77117-10MG,TGM-T77117-25MG,TGM-T77117-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Toripalimab is a recombinant, humanized immunoglobulin G4 (IgG4) monoclonal antibody that specifically targets and blocks the programmed cell death protein 1 (PD-1) immune checkpoint receptor, thereby acting as an immune checkpoint inhibitor used in clinical research for the investigation of advanced or metastatic malignancies, most notably nasopharyngeal carcinoma.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1924598-82-2]
• Target-Kategorie: PD-1/PD-L1